Acceleron Pharma (XLRN) Misses Q3 EPS by 2c

November 3, 2016 5:01 PM EDT
Get Alerts XLRN Hot Sheet
Trade XLRN Now!
Join SI Premium – FREE

Get the Pulse of the Market with's Pulse Picks. Get your Free Trial here.

Acceleron Pharma (NASDAQ: XLRN) reported Q3 EPS of ($0.55), $0.02 worse than the analyst estimate of ($0.53). Revenue for the quarter came in at $3 million versus the consensus estimate of $4.08 million.

For earnings history and earnings-related data on Acceleron Pharma (XLRN) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment